Market Overview

Janney Initiated Coverage on REITs: 10 Buys, 13 Neutrals

Share:
Related
Community Healthcare REIT Raising Money To Capitalize On Growth of Rural Medical Needs
Oppenheimer Reiterates Rating, Raises Price Target On Physicians Realty Trust On Acquisition Update And Equity Offering
Related AHH
UPDATE: Wunderlich Securities Reiterates On Armada Hoffler Properties Inc On Declining Estimates
Morning Market Losers
EdR Implements Changes in Important Finance Positions - Analyst Blog (Zacks)

Janney Capital initiated coverage on the following stocks in the REIT space...

With a Buy rating:

  • Agree Realty (NYSE: ADC) - $30 target
  • Simon Property (NYSE: SPG) - $165 target
  • Physicians Realty (NYSE: DOC) - $14 target
  • Retail Opportunity (NASDAQ: ROIC) - $15 target
  • Trade Street Residential (NASDAQ: TSRE) - $10 target
  • Healthcare Trust of American (NYSE: HTA) - $12 target
  • Realty Income (NYSE: O) - $44 target
  • Weingarten Realty (NYSE: WRI) - $30 target
  • DDR (NYSE: DDR) - $18 target
  • Glimcher Realty (NYSE: GRT) - $12 target

With a Neutral rating:

  • Armada Hoffler Properties (NYSE: AHH) - $10 target
  • American Realty Capital (NASDAQ: ARCP) - $15 target
  • Kite Realty (NYSE: KRG) - $6 target
  • Medical Properties (NYSE: MPW) - $12 target
  • Senior Housing Properties (NYSE: SNH) - $23 target
  • Inland Real Estate (NYSE: IRC) - $10 target
  • Investors Real Estate (NYSE: IRC) - $8 target
  • CBL & Associates (NYSE: CBL) - $19 target
  • Regency Centers (NYSE: REG) - $49 target
  • General Growth Properties (NYSE: GGP) - $21 target
  • Omega Health (NYSE: OHI) - $29 target
  • National Retail Properties (NYSE: NNN) - $32 target

Latest Ratings for DOC

DateFirmActionFromTo
Apr 2015BMO CapitalInitiates Coverage onOutperform
Mar 2015RBC CapitalInitiates Coverage onOutperform
Jun 2014MLVInitiates Coverage onBuy

View More Analyst Ratings for DOC
View the Latest Analyst Ratings

Posted-In: Price Target Initiation Analyst Ratings

 

Related Articles (ADC + AHH)

Around the Web, We're Loving...

Get Benzinga's Newsletters